REGENXBIO
IPOHome Page
Public · Rockville, United States · Founded 2008 · $30.0M raised
- Headquarters
- Rockville, Maryland
- Employees
- 201–500
- Founded
- 2008
- Business Model
- B2B
- Website
- regenxbio.com
- Total Funding
- $30.0M
- Last Round
- $30.0M Series C
- Rounds
- 1
- Type
- Public
About
REGENXBIO is a clinical-stage gene therapy company leveraging its NAV Technology Platform to develop treatments for rare and serious diseases.
Summary
REGENXBIO is a Biotech company based in Rockville, United States, founded in 2008. It has raised $30.0M in total across 1 round. Investors include Venrock, FoxKiser and Fidelity Biosciences.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2015
Sign up to see all 2 rounds
Series C through IPO — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/regenxbio"><img src="https://indexed.vc/api/badge/company/regenxbio" alt="REGENXBIO on Indexed.vc" width="260" height="76" /></a>